» Articles » PMID: 36118922

Systems Pharmacology Dissection of Action Mechanisms for Herbs in Osteoporosis Treatment

Overview
Journal Chin Herb Med
Publisher Elsevier
Date 2022 Sep 19
PMID 36118922
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Osteoporosis has become the biggest cause of non-fatal health issue. Currently, the limitations of traditional anti-osteoporosis drugs such as long-term ill-effects and drug resistance, have raised concerns toward complementary and alternative therapies, particularly herbal medicines and their natural active compounds. Thus, this study aimed to provide an integrative analysis of active chemicals, drug targets and interacting pathways of the herbs for osteoporosis treatment.

Methods: Here, we introduced a systematic pharmacology model, combining the absorption, distribution, metabolism, and excretion (ADME) screening model, drug targeting and network pharmacology, to probe into the therapeutic mechanisms of herbs in osteoporosis.

Results: We obtained 86 natural compounds with favorable pharmacokinetic profiles and their 58 targets from seven osteoporosis-related herbs. Network analysis revealed that they probably synergistically work through multiple mechanisms, such as suppressing inflammatory response, maintaining bone metabolism or improving organism immunity, to benefit patients with osteoporosis. Furthermore, experimental results showed that all the five compounds (calycosin, asperosaponin VI, hederagenin, betulinic acid and luteolin) enhanced osteoblast proliferation and differentiation , which corroborated the validity of this system pharmacology approach. Notably, gentisin and aureusidin among the identified compounds were first predicted to be associated with osteoporosis.

Conclusion: Herbs and their natural compounds, being characterized as the classical combination therapies, might be engaged in multiple mechanisms to coordinately improve the osteoporosis symptoms. This work may contribute to offer novel strategies and clues for the therapy and drug discovery of osteoporosis and other complex diseases.

Citing Articles

An updated review of the pharmacological effects and potential mechanisms of hederagenin and its derivatives.

Zhang H, Li Y, Liu Y Front Pharmacol. 2024; 15:1374264.

PMID: 38962311 PMC: 11220241. DOI: 10.3389/fphar.2024.1374264.


Association between the Dietary Inflammatory Index and fracture risk in older adults: a systematic review and meta-analysis.

Zheng X, Li W, Yan Y, Su Z, Huang X J Int Med Res. 2024; 52(5):3000605241248039.

PMID: 38698503 PMC: 11067643. DOI: 10.1177/03000605241248039.

References
1.
Shannon P, Markiel A, Ozier O, Baliga N, Wang J, Ramage D . Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003; 13(11):2498-504. PMC: 403769. DOI: 10.1101/gr.1239303. View

2.
Banuelos J, Lu N . A gradient of glucocorticoid sensitivity among helper T cell cytokines. Cytokine Growth Factor Rev. 2016; 31:27-35. PMC: 5050075. DOI: 10.1016/j.cytogfr.2016.05.002. View

3.
Takayanagi H . Osteoimmunology and the effects of the immune system on bone. Nat Rev Rheumatol. 2009; 5(12):667-76. DOI: 10.1038/nrrheum.2009.217. View

4.
Sordon S, Madej A, Poplonski J, Bartmanska A, Tronina T, Brzezowska E . Regioselective ortho-Hydroxylations of Flavonoids by Yeast. J Agric Food Chem. 2016; 64(27):5525-30. DOI: 10.1021/acs.jafc.6b02210. View

5.
Abdel Meguid M, Hamad Y, Swilam R, Barakat M . Relation of interleukin-6 in rheumatoid arthritis patients to systemic bone loss and structural bone damage. Rheumatol Int. 2012; 33(3):697-703. DOI: 10.1007/s00296-012-2375-7. View